Sheep in vivo models for evaluation of safety, functionality and regenerative potential of arterial graftsShow others and affiliations
2026 (English)In: MethodsX, ISSN 1258-780X, E-ISSN 2215-0161, Vol. 17, article id 104055Article in journal (Refereed) Published
Abstract [en]
Cardiovascular disease remains the leading cause of mortality worldwide. Although minimally invasive interventions have improved outcomes, open surgical reconstruction using vascular grafts is still required for many patients. Autologous vessels are preferred due to superior elastic modulus and biocompatibility; however, a substantial proportion of patients lack suitable donor vessels. Synthetic grafts perform adequately in large-diameter applications but frequently fail in small-diameter settings (≤6 mm) due to thrombosis, infection, and poor long-term patency. These limitations highlight the need for next-generation arterial grafts and robust preclinical evaluation systems. Here, we present two complementary large-animal in vivo sheep models for systematic assessment of arterial graft safety, functionality and regenerative potential. One model enables implantation of short interposition grafts (≈10 cm) in the carotid artery, while a second, novel configuration accommodates long-segment grafts (≈30 cm) in a carotid-axillary setup. Both models are integrated with a comprehensive analytical framework to evaluate patency, regeneration, biomechanical stability, immune activation and transcriptomic remodeling. Method overview:• Sheep models supporting implantation of short and long arterial grafts under physiological flow • Multimodal evaluation combining imaging, biomechanics, histology, flow cytometry, and transcriptomics • Generic platform for assessing graft functionality, safety and biological characterization.
Place, publisher, year, edition, pages
Elsevier, 2026. Vol. 17, article id 104055
Keywords [en]
Advanced therapy medicinal product (ATMP), Arteries, Large animal model, Method, Safety and functional evaluation, Vascular grafts
National Category
Cardiology and Cardiovascular Disease
Research subject
Bioinformatics
Identifiers
URN: urn:nbn:se:his:diva-26936DOI: 10.1016/j.mex.2026.104055ISI: 001831256300001PubMedID: 42529229Scopus ID: 2-s2.0-105045307401OAI: oai:DiVA.org:his-26936DiVA, id: diva2:2090141
Funder
Vinnova, 2017-02130Vinnova, 2017-02983Swedish Research Council, 2017-02983Knowledge Foundation, 2016-0330Knowledge Foundation, 2020-0014
Note
CC BY 4.0
© 2026 The Authors
Correspondence Address: J. Håkansson; RISE Research Institutes of Sweden, Division of Material and Production, Department of Medical Device and Diagnostics, Borås, Brinellgatan 4, 504 62, Sweden; email: Joakim.hakansson@ri.se
This work was supported by Swedish innovation agency Vinnova project CAMP (contract no. 2017-02130), a common call by VINNOVA and Vetenskapsrådet: Biologcal pharmaseuticals (Dnr 2017-02983), and by University of Skövde under grants from the Swedish Knowledge Foundation (#2016-0330, #2020-0014).
2026-08-062026-08-062026-08-11Bibliographically approved